Once potential synthetic lethal interactions are identified, they must be validated through experimental studies. This involves using techniques such as RNA interference (RNAi) or CRISPR-Cas9 to knock down or knockout the genes of interest in cancer cell lines. Researchers then assess cell viability to confirm whether the combination of gene disruptions leads to cell death. Animal models and clinical trials further validate these interactions in vivo.
